A detailed history of Burford Brothers, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Burford Brothers, Inc. holds 10,442 shares of ABBV stock, worth $2.11 Million. This represents 1.08% of its overall portfolio holdings.

Number of Shares
10,442
Previous 10,430 0.12%
Holding current value
$2.11 Million
Previous $1.79 Billion 15.27%
% of portfolio
1.08%
Previous 1.04%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$163.84 - $199.33 $1,966 - $2,391
12 Added 0.12%
10,442 $2.06 Billion
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $2,167 - $2,530
14 Added 0.13%
10,430 $1.79 Billion
Q1 2024

May 15, 2024

SELL
$159.82 - $182.1 $5,913 - $6,737
-37 Reduced 0.35%
10,416 $1.9 Billion
Q4 2023

Feb 16, 2024

BUY
$137.6 - $154.97 $1.44 Million - $1.62 Million
10,453 New
10,453 $1.62 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $357B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Burford Brothers, Inc. Portfolio

Follow Burford Brothers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Burford Brothers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Burford Brothers, Inc. with notifications on news.